Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myosin-1E (MYO1E) is a member of the nonmuscle class I myosin family of unconventional myosins, functioning as an actin-dependent molecular motor protein[3][4][6]. It has a characteristic long tail domain involved in crosslinking actin filaments and localizes to the cytoplasm, where it mediates intracellular movement and membrane trafficking, particularly in clathrin-mediated endocytosis and actin cytoskeleton dynamics[1][3][4][7]. MYO1E directly interacts with proteins such as focal adhesion kinase (FAK) to regulate cell adhesion, gene expression, and cancer-related processes[2], and plays a regulatory role in podocyte structure and function, with mutations causing genetic kidney disease such as focal segmental glomerulosclerosis[3][5]. It also participates in actin assembly, vesicle trafficking, and influences cell motility and rigidity, with broader implications in cancer metastasis, fibrosis, and tissue repair[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myosin-1E (MYO1E).